APO RESEARCH · REPORT
Argatroban
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
Product & engineering
Understand the product.
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
Selected research
Industry Research
Argatroban Industry Research Report 2026
Market perspective
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
Global Argatroban key players include Mitsubishi Tanabe Pharma, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, SANDOZ, etc. Global top four manufacturers hold a share nearly 60%.
Japan is the largest market, with a share about 35%, followed by Europe, and USA, both have a share about 55 percent.
Read the full market overview
In terms of product, Argatroban Injection is the largest segment, with a share over 70%. And in terms of application, the largest application is Heparin-induced thrombocytopenia (HIT), followed by Percutaneous Coronary Intervention, Cerebral arterial thrombosis.
Report Scope
This report quantifies the global Argatroban market in terms of revenue (US$ million) and, where applicable, sales volume (g), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/g) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Argatroban Market by Company
Pfizer, Inc
SANDOZ
GlaxoSmithKline Plc
fresenius-kabi
Eagle Pharmaceuticals, Inc
Mitsubishi Tanabe Pharma
Teva Pharmaceutical Industries Ltd
WEST-WARD,INC
Argatroban Segment by Type
Argatroban Powder
Argatroban Injection
Argatroban Segment by Application
Heparin-induced Thrombocytopenia (HIT)
Percutaneous Coronary Intervention
Cerebral Arterial Thrombosis
Argatroban Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Argatroban market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Argatroban and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Argatroban.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Argatroban manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Argatroban by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Argatroban in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Argatroban Powder
- Argatroban Injection
Applications
- Heparin-induced Thrombocytopenia (HIT)
- Percutaneous Coronary Intervention
- Cerebral Arterial Thrombosis
Companies covered
- Pfizer, Inc
- SANDOZ
- GlaxoSmithKline Plc
- fresenius-kabi
- Eagle Pharmaceuticals, Inc
- Mitsubishi Tanabe Pharma
- Teva Pharmaceutical Industries Ltd
- WEST-WARD,INC
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Argatroban Market Size (2021-2032)
- 2.2.2 Global Argatroban Sales (2021-2032)
- 2.2.3 Global Argatroban Market Average Price (2021-2032)
- 2.3 Argatroban by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Argatroban Powder
- 2.3.3 Argatroban Injection
- 2.4 Argatroban by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Heparin-induced Thrombocytopenia (HIT)
- 2.4.3 Percutaneous Coronary Intervention
- 2.4.4 Cerebral Arterial Thrombosis
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Argatroban Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Argatroban Sales (g) of Manufacturers (2021-2026)
- 3.3 Global Argatroban Revenue of Manufacturers (2021-2026)
- 3.4 Global Argatroban Average Price by Manufacturers (2021-2026)
- 3.5 Global Argatroban Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Argatroban, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Argatroban, Product Type & Application
- 3.8 Global Manufacturers of Argatroban, Established Date
- 3.9 Global Argatroban Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Pfizer, Inc
- 4.1.1 Pfizer, Inc Company Information
- 4.1.2 Pfizer, Inc Business Overview
- 4.1.3 Pfizer, Inc Argatroban Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Pfizer, Inc Argatroban Product Portfolio
- 4.1.5 Pfizer, Inc Recent Developments
- 4.2 SANDOZ
- 4.2.1 SANDOZ Company Information
- 4.2.2 SANDOZ Business Overview
- 4.2.3 SANDOZ Argatroban Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 SANDOZ Argatroban Product Portfolio
- 4.2.5 SANDOZ Recent Developments
- 4.3 GlaxoSmithKline Plc
- 4.3.1 GlaxoSmithKline Plc Company Information
- 4.3.2 GlaxoSmithKline Plc Business Overview
- 4.3.3 GlaxoSmithKline Plc Argatroban Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 GlaxoSmithKline Plc Argatroban Product Portfolio
- 4.3.5 GlaxoSmithKline Plc Recent Developments
- 4.4 fresenius-kabi
- 4.4.1 fresenius-kabi Company Information
- 4.4.2 fresenius-kabi Business Overview
- 4.4.3 fresenius-kabi Argatroban Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 fresenius-kabi Argatroban Product Portfolio
- 4.4.5 fresenius-kabi Recent Developments
- 4.5 Eagle Pharmaceuticals, Inc
- 4.5.1 Eagle Pharmaceuticals, Inc Company Information
- 4.5.2 Eagle Pharmaceuticals, Inc Business Overview
- 4.5.3 Eagle Pharmaceuticals, Inc Argatroban Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Eagle Pharmaceuticals, Inc Argatroban Product Portfolio
- 4.5.5 Eagle Pharmaceuticals, Inc Recent Developments
- 4.6 Mitsubishi Tanabe Pharma
- 4.6.1 Mitsubishi Tanabe Pharma Company Information
- 4.6.2 Mitsubishi Tanabe Pharma Business Overview
- 4.6.3 Mitsubishi Tanabe Pharma Argatroban Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mitsubishi Tanabe Pharma Argatroban Product Portfolio
- 4.6.5 Mitsubishi Tanabe Pharma Recent Developments
- 4.7 Teva Pharmaceutical Industries Ltd
- 4.7.1 Teva Pharmaceutical Industries Ltd Company Information
- 4.7.2 Teva Pharmaceutical Industries Ltd Business Overview
- 4.7.3 Teva Pharmaceutical Industries Ltd Argatroban Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Teva Pharmaceutical Industries Ltd Argatroban Product Portfolio
- 4.7.5 Teva Pharmaceutical Industries Ltd Recent Developments
- 4.8 WEST-WARD,INC
- 4.8.1 WEST-WARD,INC Company Information
- 4.8.2 WEST-WARD,INC Business Overview
- 4.8.3 WEST-WARD,INC Argatroban Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 WEST-WARD,INC Argatroban Product Portfolio
- 4.8.5 WEST-WARD,INC Recent Developments
5 Global Argatroban Market Scenario by Region
- 5.1 Global Argatroban Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Argatroban Sales by Region: 2021-2032
- 5.2.1 Global Argatroban Sales by Region: 2021-2026
- 5.2.2 Global Argatroban Sales by Region: 2027-2032
- 5.3 Global Argatroban Revenue by Region: 2021-2032
- 5.3.1 Global Argatroban Revenue by Region: 2021-2026
- 5.3.2 Global Argatroban Revenue by Region: 2027-2032
- 5.4 North America Argatroban Market Facts & Figures by Country
- 5.4.1 North America Argatroban Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Argatroban Sales by Country (2021-2032)
- 5.4.3 North America Argatroban Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Argatroban Market Facts & Figures by Country
- 5.5.1 Europe Argatroban Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Argatroban Sales by Country (2021-2032)
- 5.5.3 Europe Argatroban Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Argatroban Market Facts & Figures by Country
- 5.6.1 Asia Pacific Argatroban Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Argatroban Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Argatroban Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Argatroban Market Facts & Figures by Country
- 5.7.1 South America Argatroban Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Argatroban Sales by Country (2021-2032)
- 5.7.3 South America Argatroban Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Argatroban Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Argatroban Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Argatroban Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Argatroban Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Argatroban Sales by Type (2021-2032)
- 6.1.1 Global Argatroban Sales by Type (2021-2032) & (g)
- 6.1.2 Global Argatroban Sales Market Share by Type (2021-2032)
- 6.2 Global Argatroban Revenue by Type (2021-2032)
- 6.2.1 Global Argatroban Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Argatroban Revenue Market Share by Type (2021-2032)
- 6.3 Global Argatroban Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Argatroban Sales by Application (2021-2032)
- 7.1.1 Global Argatroban Sales by Application (2021-2032) & (g)
- 7.1.2 Global Argatroban Sales Market Share by Application (2021-2032)
- 7.2 Global Argatroban Revenue by Application (2021-2032)
- 7.2.1 Global Argatroban Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Argatroban Revenue Market Share by Application (2021-2032)
- 7.3 Global Argatroban Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Argatroban Value Chain Analysis
- 8.1.1 Argatroban Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Argatroban Production Mode & Process
- 8.2 Argatroban Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Argatroban Distributors
- 8.2.3 Argatroban Customers
9 Global Argatroban Analyzing Market Dynamics
- 9.1 Argatroban Industry Trends
- 9.2 Argatroban Industry Drivers
- 9.3 Argatroban Industry Opportunities and Challenges
- 9.4 Argatroban Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst